Table 4. Results of passive screening in the endemic health districts.
Year | 2017 | 2018 | 2019 | Total | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Health District | PEx | S | T | PEx | S | T | PEx | S | T | PEx | S | T |
Bouaflé | 175 | 2 | 1 | 695 | 2 | 1* | 736 | 0 | 0 | 1606 | 4 | 2 |
Sinfra | 180 | 2 | 1 | 675 | 0 | 0 | 972 | 0 | 0 | 1827 | 2 | 1 |
Total | 355 | 4 | 2 | 1370 | 2 | 1 | 1708 | 0 | 0 | 3433 | 6 | 3 |
PEx = population examined; S = number of TL-seropositive subjects; T = number of confirmed gHAT cases
*The serological case identified in Bouaflé HD in 2018